Roman Gelevan v. HHS - Influenza, Guillain-Barre syndrome (GBS) (2022)

Roman Gelevan filed a petition for compensation under the National Vaccine Injury Compensation Program on March 29, 2021, alleging that he suffered Guillain-Barre syndrome (GBS) as a result of an influenza vaccine administered on November 4, 2019. He stated that he received the vaccine in the United States, his symptoms have continued for more than six months, and he has not received prior compensation.

Respondent filed a Rule 4(c) report conceding that Petitioner is entitled to compensation, finding that Petitioner satisfied the criteria for flu-vaccine related GBS on the Vaccine Injury Table. A ruling on entitlement was issued on February 16, 2022, finding Petitioner entitled to compensation.

On April 11, 2022, Respondent filed a proffer on award of compensation, stating that Petitioner should be awarded $79,560.20, comprised of $70,000.00 for actual pain and suffering and $9,560.20 for past lost wages. Petitioner agreed with the proffered award.

The decision dated May 23, 2022, awarded Petitioner a lump sum payment of $79,560.20.